BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32240126)

  • 1. Antiretroviral Therapy and Viral Suppression Among Active Duty Service Members with Incident HIV Infection - United States, January 2012-June 2018.
    Stahlman S; Hakre S; Scott PT; Agan BK; Shell D; Gleeson T; Blaylock JM; Okulicz JF
    MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(13):366-370. PubMed ID: 32240126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.
    Hall HI; Frazier EL; Rhodes P; Holtgrave DR; Furlow-Parmley C; Tang T; Gray KM; Cohen SM; Mermin J; Skarbinski J
    JAMA Intern Med; 2013 Jul; 173(14):1337-44. PubMed ID: 23780395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in ART Prescription and Viral Suppression Among HIV-Positive Young Adults in Care in the United States, 2009-2013.
    Beer L; Mattson CL; Bradley H; Shouse RL;
    J Acquir Immune Defic Syndr; 2017 Sep; 76(1):e1-e6. PubMed ID: 28489729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The US Military HIV Natural History Study: Informing Military HIV Care and Policy for Over 30 Years.
    Agan BK; Ganesan A; Byrne M; Deiss R; Schofield C; Maves RC; Okulicz J; Chu X; O'Bryan T; Lalani T; Kronmann K; Ferguson T; Robb ML; Whitman TJ; Burgess TH; Michael N; Tramont E;
    Mil Med; 2019 Nov; 184(Suppl 2):6-17. PubMed ID: 31778201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virologic suppression among HIV-infected US Air Force members in a highly-structured programme with free access to care.
    Matthews PE; Le T; Delmar J; Okulicz JF
    Int J STD AIDS; 2015 Nov; 26(13):951-9. PubMed ID: 25505041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus transmission at each step of the care continuum in the United States.
    Skarbinski J; Rosenberg E; Paz-Bailey G; Hall HI; Rose CE; Viall AH; Fagan JL; Lansky A; Mermin JH
    JAMA Intern Med; 2015 Apr; 175(4):588-96. PubMed ID: 25706928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vital Signs: HIV Transmission Along the Continuum of Care - United States, 2016.
    Li Z; Purcell DW; Sansom SL; Hayes D; Hall HI
    MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(11):267-272. PubMed ID: 30897075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vital signs: HIV prevention through care and treatment--United States.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1618-23. PubMed ID: 22129997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Rebound Among Persons With Diagnosed HIV Who Achieved Viral Suppression, United States.
    Craw JA; Beer L; Tie Y; Jaenicke T; Shouse RL; Prejean J
    J Acquir Immune Defic Syndr; 2020 Jun; 84(2):133-140. PubMed ID: 32084054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief Report: Prevalence of Posttreatment Controller Phenotype Is Rare in HIV-Infected Persons After Stopping Antiretroviral Therapy.
    Perkins MJ; Bradley WP; Lalani T; Agan BK; Whitman TJ; Ferguson TM; Okulicz JF; Ganesan A
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):364-369. PubMed ID: 28394856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012-2013.
    Crepaz N; Tang T; Marks G; Mugavero MJ; Espinoza L; Hall HI
    Clin Infect Dis; 2016 Oct; 63(7):976-83. PubMed ID: 27358354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.
    Lecher S; Williams J; Fonjungo PN; Kim AA; Ellenberger D; Zhang G; Toure CA; Agolory S; Appiah-Pippim G; Beard S; Borget MY; Carmona S; Chipungu G; Diallo K; Downer M; Edgil D; Haberman H; Hurlston M; Jadzak S; Kiyaga C; MacLeod W; Makumb B; Muttai H; Mwangi C; Mwangi JW; Mwasekaga M; Naluguza M; Ng'Ang'A LW; Nguyen S; Sawadogo S; Sleeman K; Stevens W; Kuritsky J; Hader S; Nkengasong J
    MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(47):1332-1335. PubMed ID: 27906910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update: Routine screening for antibodies to human immunodeficiency virus, civilian applicants for U.S. military service and U.S. Armed Forces, active and reserve components, January 2012-June 2017.
    Armed Forces Health Surveillance Branch
    MSMR; 2017 Sep; 24(9):8-14. PubMed ID: 28953411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and indicators of viral suppression among persons with diagnosed HIV infection retained in care - Georgia, 2010.
    Edison L; Hughes D; Drenzek C; Kelly J;
    MMWR Morb Mortal Wkly Rep; 2014 Jan; 63(3):55-8. PubMed ID: 24452133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: routine screening for antibodies to human immunodeficiency virus, civilian applicants for U.S. military service and U.S. Armed Forces, active and reserve components, January 2008-June 2013.
    Armed Forces Health Surveillance Center (AFHSC)
    MSMR; 2013 Aug; 20(8):2-9. PubMed ID: 24011370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda.
    Nasuuna E; Kigozi J; Babirye L; Muganzi A; Sewankambo NK; Nakanjako D
    BMC Public Health; 2018 Aug; 18(1):1048. PubMed ID: 30134880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durations of military service after diagnoses of HIV-1 infections among active component members of the U.S. Armed Forces, 1990-2013.
    Brundage JF; Hunt DJ; Clark LL
    MSMR; 2015 Aug; 22(8):9-12. PubMed ID: 26295975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.